| ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit | Target Domain Name | Detail |
|---|---|---|---|---|---|---|
| ACoVP100441 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.000048 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100442 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 4.74 | µg/mL | RBD of SARS-CoV-2 | more |
| ACoVP100443 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 2.39 ± 0.2 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100444 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 3.72 ± 0.37 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100445 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >7.5 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100446 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >7.5 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100447 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >7.5 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100448 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 1.9 ± 0.14 | µM | RBD of SARS-CoV-2 | more |
| ACoVP100449 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.01 ± 0.008 | µM | more | |
| ACoVP100450 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC90 | 0.098 ± 0.057 | µM | more | |
| ACoVP100451 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.293 ± 0.06 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100452 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC90 | >0.9 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100453 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >0.65 | µM | more | |
| ACoVP100454 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC90 | >1 | µM | more | |
| ACoVP100455 | Severe acute respiratory syndrome coronavirus 2_D614G(SARS-CoV-2_D614G) | IC50 | 0.008 ± 0.004 | µM | more | |
| ACoVP100456 | Severe acute respiratory syndrome coronavirus 2_D614G(SARS-CoV-2_D614G) | IC90 | 0.096 ± 0.05 | µM | more | |
| ACoVP100457 | Severe acute respiratory syndrome coronavirus 2_D614G(SARS-CoV-2_D614G) | IC50 | 0.261 ± 0.136 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100458 | Severe acute respiratory syndrome coronavirus 2_D614G(SARS-CoV-2_D614G) | IC90 | 0.892 ± 0.1 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100459 | Severe acute respiratory syndrome coronavirus 2_D614G(SARS-CoV-2_D614G) | IC50 | 1 | µM | more | |
| ACoVP100460 | Severe acute respiratory syndrome coronavirus 2_D614G(SARS-CoV-2_D614G) | IC90 | >1 | µM | more |